Crescent Biopharma Inc
F:C68
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Crescent Biopharma Inc
F:C68
|
US |
|
C
|
Cirralto Ltd
OTC:CROTF
|
AU |
|
Agung Podomoro Land Tbk PT
IDX:APLN
|
ID |
|
Vivos Therapeutics Inc
NASDAQ:VVOS
|
US |
Wall Street
Price Targets
C68 Price Targets Summary
Crescent Biopharma Inc
According to Wall Street analysts, the average 1-year price target for
C68
is 23.87 EUR
with a low forecast of 17.73 EUR and a high forecast of 29.32 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is C68's stock price target?
Price Target
23.87
EUR
According to Wall Street analysts, the average 1-year price target for
C68
is 23.87 EUR
with a low forecast of 17.73 EUR and a high forecast of 29.32 EUR.
What is Crescent Biopharma Inc's Revenue forecast?
Projected CAGR
-9%
For the last 13 years the
compound annual growth rate for
Crescent Biopharma Inc's revenue is
-3%.
The projected
CAGR
for the next 3 years is
-9%.
